FibroGen (FGEN) News Today $9.25 +0.88 (+10.51%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$9.35 +0.10 (+1.07%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period FibroGen, Inc.: FibroGen Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 12 at 7:54 PM | finanznachrichten.deFibroGen, Inc. (FGEN) Q2 2025 Earnings Call TranscriptAugust 12 at 2:09 AM | seekingalpha.comFibroGen Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 11 at 4:02 PM | globenewswire.comUncovering Potential: FibroGen's Earnings PreviewAugust 8, 2025 | benzinga.comFibroGen stock surges after FDA feedback on roxadustat for MDS anemiaAugust 8, 2025 | investing.comFibroGen Announces Positive Type C Meeting with the FDA for Roxadustat in Patients with Anemia Associated with Lower-Risk Myelodysplastic SyndromesAugust 8, 2025 | finance.yahoo.comFibroGen to Report Second Quarter 2025 Financial ResultsAugust 4, 2025 | globenewswire.comFibroGen, Inc (NASDAQ:FGEN) Director James A. Schoeneck Acquires 23,567 SharesJuly 3, 2025 | insidertrades.comFibroGen Inc.June 24, 2025 | marketwatch.comFibroGen (NASDAQ:FGEN) Trading Down 6.7% - What's Next?June 17, 2025 | marketbeat.comFibroGen To Implement 1-for-25 Reverse Stock SplitJune 14, 2025 | nasdaq.comFibroGen, Inc. Announces 1-for-25 Reverse Stock Split Effective June 16, 2025June 14, 2025 | nasdaq.comFibroGen Enters Relicensing Agreement with HiFiBiOJune 13, 2025 | marketwatch.comFibroGen Announces 1-for-25 Reverse Stock SplitJune 12, 2025 | globenewswire.comFibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of DirectorsJune 9, 2025 | globenewswire.comFibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipelineMay 13, 2025 | msn.comFibroGen, Inc. (NASDAQ:FGEN) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comFibroGen, Inc.: FibroGen Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13, 2025 | finanznachrichten.deFibroGen, Inc. (FGEN) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comFibroGen Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 12, 2025 | globenewswire.comA Preview Of FibroGen's EarningsMay 10, 2025 | benzinga.comDuchenne Muscular Dystrophy (DMD) Pipeline Insight Report 2025, Featuring Analysis of Vamorolone (Santhera), Givinostat (Italfarmaco), and Pamrevlumab (Fibrogen)May 8, 2025 | globenewswire.comFibroGen, Inc. to Announce Q1 2025 Financial Results and Host Conference Call on May 12May 7, 2025 | nasdaq.comFibroGen to Report First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comWilliam Blair Keeps Their Hold Rating on FibroGen (FGEN)April 2, 2025 | markets.businessinsider.comFibroGen to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 2, 2025 | globenewswire.comFibroGen extends merger option deadline with FortisMarch 30, 2025 | investing.comFibroGen announces publication of results from Phase 1 study of FG-3246March 29, 2025 | markets.businessinsider.comFibroGen Down on Peer-Review PublicationMarch 28, 2025 | baystreet.caInsider Buying: FibroGen, Inc. (NASDAQ:FGEN) CEO Purchases 145,000 Shares of StockMarch 26, 2025 | insidertrades.comFibroGen, Inc. (NASDAQ:FGEN) Director Buys $87,500.00 in StockMarch 25, 2025 | insidertrades.comFibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | msn.comFibroGen options imply 18.1% move in share price post-earningsMarch 18, 2025 | markets.businessinsider.comFibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 18, 2025 | finanznachrichten.deFibroGen reports Q4 EPS 18c, consensus (20c)March 18, 2025 | markets.businessinsider.comFibroGen (FGEN) Gets a Hold from William BlairMarch 18, 2025 | markets.businessinsider.comFibroGen, Inc. (FGEN) Q4 2024 Earnings Call TranscriptMarch 17, 2025 | seekingalpha.comFibroGen Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 17, 2025 | globenewswire.comFibroGen to Report Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comFibroGen (FGEN) Expected to Announce Quarterly Earnings on MondayFebruary 22, 2025 | marketbeat.comFibroGen (NASDAQ:FGEN) Receives Buy Rating from HC WainwrightFebruary 21, 2025 | marketbeat.comStockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN)February 21, 2025 | marketbeat.comFibroGen to sell China business, extend cash runway to focus on cancer drugsFebruary 20, 2025 | bizjournals.comFibroGen stock soars on China unit saleFebruary 20, 2025 | in.investing.comThis Small Cap Soared Following Subsidiary Sale Announcement Worth $160MFebruary 20, 2025 | msn.comFibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 MillionFebruary 20, 2025 | finance.yahoo.comFibroGen China sale ‘shrewd strategic transaction,’ says H.C. WainwrightFebruary 20, 2025 | markets.businessinsider.comFibroGen sells China unit to AstraZeneca in deal worth $160 millionFebruary 20, 2025 | reuters.comFibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 MillionFebruary 20, 2025 | globenewswire.comFibroGen, Inc. (NASDAQ:FGEN) Short Interest Down 5.2% in JanuaryFebruary 18, 2025 | marketbeat.com Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address FGEN Media Mentions By Week FGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FGEN News Sentiment▼0.000.75▲Average Medical News Sentiment FGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FGEN Articles This Week▼91▲FGEN Articles Average Week Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Citius Oncology News Today Kyverna Therapeutics News Today Compugen News Today TuHURA Biosciences News Today ALT5 Sigma News Today Black Diamond Therapeutics News Today Protalix BioTherapeutics News Today Seres Therapeutics News Today Genelux News Today Spero Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FGEN) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access